Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
268
-
Total shares
-
74M
-
Shares change
-
+6.22M
-
Total reported value, excl. options
-
$4.15B
-
Value change
-
+$368M
-
Put/Call ratio
-
0.43
-
Number of buys
-
124
-
Number of sells
-
-130
-
Price
-
$56.07
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q4 2022
274 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q4 2022.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 268 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74M shares
of 77.6M outstanding shares and own 95.44% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.15M shares), BlackRock Inc. (7.14M shares), MORGAN STANLEY (6.3M shares), WELLINGTON MANAGEMENT GROUP LLP (5.57M shares), Champlain Investment Partners, LLC (5.26M shares), Capital Research Global Investors (3.82M shares), ALLIANCEBERNSTEIN L.P. (2.9M shares), COOKE & BIELER LP (2.73M shares), JANUS HENDERSON GROUP PLC (2.64M shares), and Clearbridge Investments, LLC (2.58M shares).
This table shows the top 268 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.